Coromandel International Ltd. - Research Center
506395 COROMANDEL Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 3,899.84 | 5,450.33 | 6,985.56 | 5,693.48 | 5,470.66 |
| Operating profit | 268.79 | 358.24 | 1,064.27 | 709.54 | 398.98 |
| Interest | 60.90 | 37.83 | 46.06 | 40.46 | 51.73 |
| Gross profit | 335.03 | 380.12 | 1,063.92 | 715.61 | 395.78 |
| EPS (Rs) | 7.11 | 8.24 | 25.88 | 17.19 | 8.90 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 127.14 | 59.71 | 45.71 | 46.53 | 48.53 |
| Stock adjustment | -344.80 | -389.09 | 1,527.66 | -1,055.69 | 270.89 |
| Raw material | 2,851.89 | 3,578.52 | 3,091.87 | 3,970.89 | 3,562.56 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 169.33 | 182.51 | 174.64 | 163.59 | 163.60 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 954.63 | 1,720.15 | 1,127.12 | 1,905.15 | 1,074.63 |
| Provisions made | - | - | - | - | - |
| Depreciation | 61.78 | 60.36 | 52.07 | 47.99 | 44.33 |
| Taxation | 63.79 | 77.25 | 249.85 | 162.34 | 89.92 |
| Net profit / loss | 209.46 | 242.51 | 762.00 | 505.28 | 261.53 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 29.44 | 29.44 | 29.44 | 29.40 | 29.40 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 6.89 | 6.57 | 15.24 | 12.46 | 7.29 |
| GPM (%) | 8.32 | 6.90 | 15.13 | 12.47 | 7.17 |
| NPM (%) | 5.20 | 4.40 | 10.84 | 8.80 | 4.74 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis